author-photo

Michal Mandelboim

Tel Aviv University
United States Public Health Service
Sheba Medical Center

105

Papers

2136

Citations

Citation Trend

Filter By

Papers (76) Sort By

Journal Conference Others

Immunoglobulin (Ig)A seropositivity against SARS-CoV-2 in healthcare workers in Israel, 4 April to 13 July 2020: an observational study

2021 Eurosurveillance
Show All
- Source
- Cite
- Save
Citations (0)
Improved sensitivity, safety, and rapidity of COVID-19 tests by replacing viral storage solution with lysis buffer.

2021 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (3)
TaffiX® nasal powder spray forms an effective barrier against infectious new variants of SARS-CoV-2 (COVID-19)

2021
Show All
- Source
- Cite
- Save
Citations (0)
Rapid and High-Throughput Reverse Transcriptase Quantitative PCR (RT-qPCR) Assay for Identification and Differentiation between SARS-CoV-2 Variants B.1.1.7 and B.1.351.

2021 Microbiology spectrum
Show All
- Source
- Cite
- Save
Citations (1)
The unique evolutionary dynamics of the SARS-CoV-2 Delta variant

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (2)
Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2.

2021 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (34)
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel.

2021 Eurosurveillance
Show All
- Source
- Cite
- Save
Citations (44)
Rapid And high throughput RT-qPCR assay for identification and differentiation between SARS-CoV-2 variants B.1.1.7 and B.1.351

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience.

2021 Journal of Heart and Lung Transplantation
Show All
- Source
- Cite
- Save
Citations (3)
Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19, A double-blind, randomized placebo-controlled trial.

2021
Show All
- Source
- Cite
- Save
Citations (3)